Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.72% |
| Dec 31, 2025 | -3.22% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | 0.58% |
| Mar 31, 2025 | 5.40% |
| Dec 31, 2024 | 8.00% |
| Sep 30, 2024 | 9.05% |
| Jun 30, 2024 | 6.81% |
| Mar 31, 2024 | 25.91% |
| Dec 31, 2023 | 31.37% |
| Sep 30, 2023 | 34.99% |
| Jun 30, 2023 | 36.46% |
| Mar 31, 2023 | 36.01% |
| Dec 31, 2022 | 44.53% |
| Sep 30, 2022 | 45.95% |
| Jun 30, 2022 | 48.06% |
| Mar 31, 2022 | 179.49% |
| Dec 31, 2021 | 41.83% |
| Sep 30, 2021 | 54.21% |
| Jun 30, 2021 | 58.52% |
| Mar 31, 2021 | 59.84% |
| Dec 31, 2020 | 52.98% |
| Sep 30, 2020 | 47.93% |
| Jun 30, 2020 | 40.88% |
| Mar 31, 2020 | 40.14% |
| Dec 31, 2019 | 37.82% |
| Sep 30, 2019 | 36.44% |
| Jun 30, 2019 | 50.94% |
| Mar 31, 2019 | 46.83% |
| Dec 31, 2018 | 36.01% |
| Sep 30, 2018 | 33.56% |
| Jun 30, 2018 | 32.20% |
| Mar 31, 2018 | 39.40% |
| Dec 31, 2017 | 27.75% |
| Sep 30, 2017 | 25.95% |
| Jun 30, 2017 | 21.92% |
| Mar 31, 2017 | -37.14% |
| Dec 31, 2016 | 20.02% |
| Sep 30, 2016 | 5.81% |